Close

More on OCUP

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+60.7% Growth)
- Ratings (10.0 Score)

Upcoming Events

- Earnings (5/3/24)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Ocuphire Pharma (NQ:OCUP)
Delayed: 1.66 -0.01 (0.6%)
Prev. Close $1.67  
Open$1.67 
52 Wk High$ 
52 Wk Low$ 
Day High$1.71 
Day Low$1.59 
P/E N/A  
EPS$ 
Volume234,978 

Friends, Peers and Foes (?): VTRS (more...)

Apr 17, 2024 04:24 PM Form 8-K Ocuphire Pharma, Inc. For: Apr 11
Apr 15, 2024 04:12 PM Form 4 Ocuphire Pharma, Inc. For: Apr 11 Filed by: Pepose Jay
Apr 11, 2024 10:03 AM First Patient Enrolled in LYNX-2 Phase 3 Study Evaluating Phentolamine Ophthalmic Solution 0.75% (PS) for the Treatment of Decreased Visual Acuity Under Low Light Conditions Following Keratorefractive
Apr 1, 2024 07:15 AM Ocuphire Pharma (OCUP) Announces US Launch of RYZUMVl
Apr 1, 2024 07:14 AM Ocuphire Announces the U.S. Commercial Launch of RYZUMVl™ (Phentolamine Ophthalmic Solution 0.75%) by its Partner Viatris
Mar 27, 2024 04:28 PM Form 8-K Ocuphire Pharma, Inc. For: Mar 27
Mar 25, 2024 04:45 PM Form 4 Ocuphire Pharma, Inc. For: Mar 21 Filed by: SCHACHLE JOSEPH K
Mar 25, 2024 04:40 PM Form 4 Ocuphire Pharma, Inc. For: Mar 21 Filed by: Jhaveri Nirav S.
Mar 20, 2024 04:19 PM Form 4 Ocuphire Pharma, Inc. For: Mar 18 Filed by: Magrath George
Mar 8, 2024 05:21 PM Form 10-K Ocuphire Pharma, Inc. For: Dec 31
View All Articles

Entities mentioned with OCUP

View All Entities